New Lung Cancer Rx Targets Common Mutation

The US Food and Drug Administration (FDA) has approved a new lung cancer treatment that targets a common tumor mutation.

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments